MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2023 International Congress

    Deep Brain Stimulation Outcomes in Underreported Dystonias: A Case Series

    B. Dahlben, N. Bukhari-Parlakturk, DA. Turner, S. Harward, D. Southwell, KT. Mitchell (Durham, USA)

    Objective: To describe the results of pallidal Deep Brain Stimulation (DBS) in a single center for dystonia subtypes which previously have not been widely reported.…
  • 2023 International Congress

    Development of a Vibro-Tactile Stimulation wristband for targeted therapy of Focal Task Specific Dystonias

    S. Arjun, A. Singh, H. Singh, R. Jain, I. Ahuja (Chandigarh, India)

    Objective: To design and develop a wristband that provides vibro-tactile stimulation as a sensory geste/trick for patients with FTSDs. The device will offer different frequencies…
  • 2022 International Congress

    Characterization of routine botulinum toxin (BoNT) therapy and patient population in cervical dystonia

    B. Waeschle, H. Stark, P. Albrecht (Düsseldorf, Germany)

    Objective: We conducted a survey to characterize real-world treatment of CD patients with focus on treatment duration, clinical parameters and awareness of clinical resistance as…
  • 2022 International Congress

    DBS for a patient with KMT2B-SHANK2 related dystonia

    L. Pan, G. Riboldi, A. Mogilner, C. Toro, S. Frucht (New York, USA)

    Objective: Describe a case of deep brain stimulation (DBS) outcome for a patient with pathogenic variants of Shank2 and KMT2B genes. Background: Prior reports have…
  • 2022 International Congress

    Assessment of mood symptoms and influence on disease in cervical dystonia

    S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To compare mood symptom rating scales and influence of anxiety and depressive symptoms on motor severity and aspects of quality of life. Background: Cervical…
  • 2022 International Congress

    Transcranial magnetic resonance-guided focused ultrasound in Lance-Adams syndrome

    R. Galimova, YU. Sidorova, G. Akhmadeeva, O. Kachemaeva, D. Krekotin, I. Buzaev, N. Muhamadeeva (Ufa, Russian Federation)

    Objective: The objective is to present the first reported case of a patient with post-hypoxic myoclonus (PHM) who underwent noninvasive MR-guided Focused Ultrasound Treatment (MRgFUS).…
  • 2022 International Congress

    Internal globus pallidus deep brain stimulation in ACTB-related deafness-dystonia

    D. Macias-Garcia, S. Jesús, A. Adarmes-Gomez, L. Muñoz-Delgado, F. Carrillo, P. Mir (Seville, Spain)

    Objective: To describe the response to deep brain stimulation (DBS) in a patient with ACTB-related deafness-dystonia syndrome with three years of follow-up and to review…
  • 2022 International Congress

    SETTING UP A PEDIATRIC DEEP BRAIN STIMULATION UNIT

    J. Ferrero-Turrión, A. Salazar-Villacorta, A. Bescos, G. Español, L. Ispierto, R. Alvarez, M. Tardáguila, J. Muñoz, L. Ventura-Expósito, B. Pérez-Dueñas (Barcelona, Spain)

    Objective: Describe our 2-year experience establishing a pediatric deep brain stimulation (pDBS) service in a tertiary hospital and report our outcomes. Background: DBS is a…
  • 2022 International Congress

    Evaluation of Atrophy after Botulinum Toxin injection for Cervical Dystonia by MRI

    M. Salari, M. Etemadifar, S. Parvizi (Tehran, Islamic Republic of Iran)

    Objective: Cervical Dystonia (CD) is the most common form of focal dystonia involving the muscles of the neck and sometimes the shoulders. 1 There are several categories…
  • 2022 International Congress

    Impact of botulinum toxin treatment on gait in focal dystonia

    J. Cuinat, B. Debu, P. Pelissier, A. Castrioto, S. Meoni, S. Potel, V. Fraix, E. Moro (Grenoble, France)

    Objective: To study the effects of botulinum neurotoxin (BTX) treatment on gait characteristics in patients with blepharospasm and cervical dystonia. Background: The impact of focal…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Marc Chagall’s L’homme à La Tète Renversée (Man with His Head Thrown Back) – An Artistic Depiction of Severe Retrocollis in Neurodegeneration with Brain Iron Accumulation
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Isolated ZIC4 antibody associated paraneoplastic cerebellar degeneration
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley